Latest Content

Forging multistakeholder partnerships and prioritizing high-impact specialities can help convert market volatility to an advantage.

Greater reliance on travel nurses may be associated with more hospital complications.

On paper, the OCM cost Medicare millions. A decade later, physicians say its lessons are priceless.

Nancy Lin, MD, explains how an AI model compares with genomic classifiers in HR+/HER2- early breast cancer, with implications for cost and access.

Re-engagement strategies for hepatitis B show promise in the US, but data gaps and structural barriers are slowing progress toward WHO elimination targets.

Shields Health Solutions is collaborating with Baptist Health to launch an integrated onsite specialty pharmacy at Baptist MD Anderson Cancer Center.

The FDA approved a supplemental BLA for Organon's tocilizumab biosimilar Tofidence.

A review finds diet, micronutrients, aerobic exercise, and mental health screening complement psoriasis treatment, lowering severity and comorbidity risk.

CHMP issued a positive opinion for nerandomilast in IPF and PPF, bringing the therapy closer to European Union approval.